Buy Cagrilintide – Research Peptide | PEPTEX
37-residue amylin-analogue synthetic peptide. CAS 2418548-51-5. Purity ≥98% by HPLC. Features a C18 fatty diacid side chain at Lys²³ enabling extended albumin binding. White lyophilised powder; reconstitute in sterile water immediately before use. Supplied in a sealed borosilicate glass vial. Intended for laboratory and research use only. Store at −20°C; protect from light and moisture.
Price: EUR | Brand: PEPTEX | In Stock | EU-wide delivery, up to 7 business days
Rating: 4.9/5 (179 reviews)
Customer Reviews
Luca.m — ★★★★★
Coming back for my fourth order. Cagrilintide became a permanent part of my protocol after the first cycle convinced me. The amylin pathway adds something that incretins alone can't provide.
Enrique — ★★★★★
the combination approach of cagri with a GLP-1 is where the magic is. running both from peptex. the quality of both products is identical — clean, potent, well-packaged. support helped me design the protocol
adam_fit — ★★★★★
Ordered after their consultation team recommended trying a different pathway since GLP-1 alone wasn't enough for me. Cagrilintide was the suggestion. 6 weeks in, noticeable difference. Glad I asked.
Bernd84 — ★★★★★
effective for appetite but the nausea was worse for me than with tirze. had to start at a very low dose and titrate slower than the typical protocol. once i found my dose it's been smooth. the satiety effect is strong
Jakub88 — ★★★★
Got cagrilintide after plateauing on tirzepatide for 2 months. The combination approach is what interested me (different receptors). Added it alongside tirz and the plateau broke within 3 weeks. Interesting synergy.
Available Sizes
- 5mg — 124 EUR
- 10mg — 184 EUR
Storage Recommendations
| Condition | Temperature | Duration |
|---|---|---|
| Lyophilised | -20°C | Up to 24 months |
| Reconstituted | 2-8°C | Up to 12 weeks with Peptide Reconstitution Solution (Acidic) |
Research References
- Cagrilintide plus semaglutide 2.4 mg for weight management — Phase 1b — Lancet / PubMed (2021)
- Once-weekly cagrilintide for weight management — Phase 2 dose-finding — Lancet / PubMed (2021)
💬 Комментарии